Skip to main content
Terug
HNORY logo

Harvey Norman Holdings Limited

Datakwaliteit: 100%
Overbought
HNORY
OTC Consumer Cyclical Specialty Retail
€ 12,50
€ 0,00 (0,00%)
Marktkapitalisatie: 3,12B
Dagbereik
€ 12,50 € 20,14
52-Weeksbereik
€ 12,14 € 20,14
Volume
2
50D / 200D Gem.
€ 12,50 / € 12,50
Vorige Slotkoers
€ 12,50

Koershistorie

Financiële Trends

Sectorvergelijking

vs Consumer Cyclical sector mediaan (610 peers)

Metriek Aandeel Sector Mediaan
P/E 6,0 11,1
P/B 0,7 1,4
ROE % 11,1 10,7
Net Margin % 12,6 5,1
Rev Growth 5Y % -0,2 8,1
D/E 0,5 0,8

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 € 0,00
€ 0,00 – € 0,00
4,8 B 0
FY2026 € 0,00
€ 0,00 – € 0,00
4,7 B 0

Belangrijkste Punten

Revenue declined -0,16% annually over 5 years
Earnings grew 46,97% over the past year
ROE of 11,14% — decent returns on equity
Debt/Equity of 0,48 — conservative balance sheet
Generating 510,74M in free cash flow
P/E of 6,01 — trading at a low valuation

Groei

Revenue Growth (5Y)
-0,16%
Revenue (1Y)5,09%
Earnings (1Y)46,97%
FCF Growth (3Y)1,83%

Kwaliteit

Return on Equity
11,14%
ROIC4,28%
Net Margin12,57%
Op. Margin9,83%

Veiligheid

Debt / Equity
0,48
Current Ratio1,38
Interest Coverage3,44

Waardering

P/E Ratio
6,01
P/B Ratio0,65
EV/EBITDA12,66
Dividend Yield0,06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5,09% Revenue Growth (3Y) 1,71%
Earnings Growth (1Y) 46,97% Earnings Growth (3Y) -2,01%
Revenue Growth (5Y) -0,16% Earnings Growth (5Y) -11,42%
Profitability
Revenue (TTM) 4,12B Net Income (TTM) 518,02M
ROE 11,14% ROA 6,19%
Gross Margin 50,96% Operating Margin 9,83%
Net Margin 12,57% Free Cash Flow (TTM) 510,74M
ROIC 4,28% FCF Growth (3Y) 1,83%
Safety
Debt / Equity 0,48 Current Ratio 1,38
Interest Coverage 3,44 Dividend Yield 0,06%
Valuation
P/E Ratio 6,01 P/B Ratio 0,65
P/S Ratio 0,76 PEG Ratio 0,18
EV/EBITDA 12,66 Dividend Yield 0,06%
Market Cap 3,12B Enterprise Value 5,13B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4,12B 3,92B 3,98B 4,14B 4,15B
Net Income 518,02M 352,45M 539,52M 811,53M 841,41M
EPS (Diluted) 2,10 1,40 2,15 3,25 3,35
Gross Profit 2,10B 1,99B 1,94B 2,12B 2,16B
Operating Income 405,12M 361,21M 475,07M 733,15M 845,99M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,37B 7,93B 7,67B 7,25B 6,67B
Total Liabilities 3,53B 3,39B 3,21B 2,95B 2,78B
Shareholders' Equity 4,80B 4,50B 4,43B 4,26B 3,86B
Total Debt 2,29B 2,28B 2,18B 1,90B 1,74B
Cash & Equivalents 279,69M 273,47M 218,75M 248,80M 264,43M
Current Assets 1,89B 1,84B 1,83B 1,91B 1,73B
Current Liabilities 1,37B 796,24M 738,66M 989,81M 1,15B

Strategiescores

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
#660 of 1052
39
#645 of 827
29

Recente Activiteit

Ingestapt Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt Defensive Investing (Benjamin Graham)
Mar 24, 2026
Ingestapt Cash Flow Compounder
Mar 24, 2026